Article Text

other Versions

PDF
Risk of bilateral visual impairment in persons with amblyopia: The Rotterdam Study
  1. Redmer Van Leeuwen (r.vanleeuwen{at}erasmusmc.nl),
  2. Marinus JC Eijkemans (m.eijkemans{at}erasmusmc.nl),
  3. Johannes R Vingerling (j.vingerling{at}erasmusmc.nl),
  4. Albert Hofman (a.hofman{at}erasmusmc.nl),
  5. Paulus TVM de Jong (p.dejong{at}nin.knaw.nl),
  6. Huib J Simonsz (simonsz{at}compuserve.com)
  1. Erasmus MC, Netherlands
  2. Erasmus MC, Netherlands
  3. Erasmus MC, Netherlands
  4. Erasmus MC, Netherlands
  5. Netherlands Institute of Neuroscience, Netherlands
  6. Erasmus MC, Netherlands

    Abstract

    Background: The excess risk of bilateral visual impairment (BVI, bilateral visual acuity <0.5) among persons with amblyopia is an argument for screening for amblyopia. However, data are rare.

    Methods: We estimated this risk by determining the incidence of BVI within The Rotterdam Study, a population-based cohort of subjects aged 55 years or over (n=5220), including 192 persons with amblyopia (3.7%). With a multi-state lifetable, the lifetime risk and excess period spent with BVI were determined.

    Results: The relative risk of BVI for amblyopes was 2.6 (95% confidence interval 1.4-4.5). For amblyopic persons, the lifetime risk of BVI was 18% while they lived on average 7.2 years with BVI. For non-amblyopic persons, these figures were 10% and 6.7 years, respectively.

    Conclusion: Amblyopia nearly doubles the life-time risk of BVI and affected persons spent an extra 6 months with BVI. This study provides data for future cost-effectiveness analyses.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles